Evidence map›Paper›PMID 42054221›Full record

ArticleJournal of the American Chemical Society2026

Chemoenzymatic Synthesis with Plant Oxidases and Metabolic Engineering Enable Rapid Access to Rare Gibberellins.

Ahmed Arafa, Jennifer Gerke, Russell Cox, Jakob Franke

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. RSC advances · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ahmed ArafaCentre of Biomolecular Drug Research, Leibniz University Hannover, Schneiderberg 38, Hannover 30167, Germany.ORCID 0000-0001-5869-4568
Jennifer GerkeCentre of Biomolecular Drug Research, Leibniz University Hannover, Schneiderberg 38, Hannover 30167, Germany.
Russell CoxCentre of Biomolecular Drug Research, Leibniz University Hannover, Schneiderberg 38, Hannover 30167, Germany.ORCID 0000-0002-1844-0157
Jakob FrankeCentre of Biomolecular Drug Research, Leibniz University Hannover, Schneiderberg 38, Hannover 30167, Germany.ORCID 0000-0002-7603-6232

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gibberellins are structurally complex diterpenoid plant hormones with widespread agricultural applications. However, of the 136 known congeners found in nature, very few are easily accessible, preventing further research regarding their biological function. In biosynthesis, oxidases from plants generate the diverse oxidation patterns of natural gibberellins. Plant oxidases, in contrast to microbial oxidases, are very challenging to use for chemoenzymatic synthesis. Here, we develop a chemoenzymatic and metabolic engineering platform using plant oxidases that allows the production and full characterization of eight rare gibberellins as well as 16

Indexed as

GibberellinsMetabolic EngineeringNicotianaOxidoreductasesAspergillus oryzaeOxidation-ReductionGibberellinsOxidoreductases

Identifiers

PMID42054221
PMCPMC13185120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.